等待开盘 10-01 09:30:00 美东时间
+0.020
+0.08%
今日重点评级关注:古根海姆:维持Damora Therapeutics"买入"评级,目标价从40美元升至60美元;HC Wainwright & Co.:维持Rezolute"买入"评级,目标价从5美元升至10美元
09-28 12:37
Morgan Stanley analyst Michael Cyprys maintains WisdomTree (NYSE:WT) with a Equal-Weight and raises the price target from $21 to $27.
09-25 21:43
WisdomTree plans to provide eligible U.S. investors with another way to invest in WTGXX, supported by MoonPay’s technology and network of more than 35 million accounts. WisdomTree, Inc. (NYSE:WT), a global financial innovator, and MoonPay, the global financial technology company powering the movemen...
09-17 19:07
今日重点评级关注:Ascendiant Capital:维持Alzamend Neuro"买入"评级,目标价从25美元升至26美元;Tigress Financial:维持Legence"买入"评级,目标价从125美元升至130美元
08-20 08:39
Northland Capital Markets analyst Mike Grondahl maintains WisdomTree (NYSE:WT) with a Outperform and raises the price target from $22 to $26.
08-20 02:00
华盛资讯8月6日讯,智慧树公布2026财年Q2业绩,公司Q2营收1.77亿美元,同比增长57.3%,归母净利润0.44亿美元,同比增长78.7%。
08-06 07:32
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
卓越睿新(02687.HK)智慧树网2026年前7个月公开中标持续释放亮点:压倒性高分中标、985高校密集签约、单一来源采购和老客户多次复购频现、交付排期延至...
08-04 08:40
Oppenheimer analyst Chris Kotowski maintains WisdomTree (NYSE:WT) with a Outperform and raises the price target from $21 to $22.
08-03 22:26
华盛资讯7月31日讯,智慧树公布2026财年Q2业绩,公司Q2营收1.77亿美元,同比增长57.3%,归母净利润0.44亿美元,同比增长78.7%。
07-31 20:18